Please join us for a conversation with Lon Cardon, Ph.D., FMedSci, an internationally renowned human geneticist, who joined The Jackson Laboratory as president and chief executive officer in November 2021. From 2017 to 2021, he was chief scientific officer and chief scientific strategy officer at BioMarin Pharmaceutical Inc., a rare disease biotechnology company, where he led a strategic repositioning from ultra-rare genetic diseases to broader genetic disorders. Before joining BioMarin, Cardon held leadership roles at GlaxoSmithKline.